Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
TJX Companies
TJX
$155B
| $301K | 0.02% |
6,300
-222,672
| -97% | -$12.8M |
|
752
AMN Healthcare
AMN
$1.34B
| $299K | 0.02% |
+5,172
| New | +$354K |
|
753
Polaris
PII
$3.66B
| $299K | 0.02% |
6,200
+3,912
| +171% | +$321K |
|
754
Universal Health Services
UHS
$10.4B
| $299K | 0.02% |
3,021
+28
| +0.9% | +$3.54K |
|
755
Commerce Bancshares
CBSH
$8.41B
| $297K | 0.02% |
+7,903
| New | +$374K |
|
756
Invesco
IVZ
$14.3B
| $297K | 0.02% |
32,700
-7,859
| -19% | -$119K |
|
757
Viatris
VTRS
$19B
| $297K | 0.02% |
19,932
-688,594
| -97% | -$13.2M |
|
|
XLNX
758
DELISTED
Xilinx Inc
XLNX
| $297K | 0.02% |
3,808
-9,862
| -72% | -$859K |
|
|
IMMU
759
DELISTED
Immunomedics Inc
IMMU
| $297K | 0.02% |
22,020
+3,607
| +20% | +$60.7K |
|
760
Huazhu Hotels Group
HTHT
$15B
| $296K | 0.02% |
10,300
-139,363
| -93% | -$4.74M |
|
761
Sprouts Farmers Market
SFM
$8.03B
| $296K | 0.02% |
15,900
-16,200
| -50% | -$272K |
|
|
REGI
762
DELISTED
Renewable Energy Group, Inc.
REGI
| $296K | 0.02% |
+14,400
| New | +$364K |
|
763
Groupon
GRPN
$798M
| $295K | 0.02% |
15,065
-63,655
| -81% | -$2.51M |
|
|
INOV
764
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $295K | 0.02% |
+17,700
| New | +$336K |
|
|
AVB
765
DELISTED
AvalonBay Communities
AVB
| $294K | 0.02% |
+2,000
| New | +$403K |
|
766
Agnico Eagle Mines
AEM
$110B
| $293K | 0.02% |
7,355
-807
| -10% | -$42.5K |
|
767
SAP
SAP
$252B
| $292K | 0.02% |
2,646
+401
| +18% | +$50.6K |
|
768
Carlyle Secured Lending
CGBD
$788M
| $291K | 0.02% |
+55,800
| New | +$661K |
|
769
Dorian LPG
LPG
$2.2B
| $291K | 0.02% |
+33,400
| New | +$395K |
|
|
BBT
770
Beacon Financial Corp
BBT
$2.65B
| $290K | 0.02% |
+19,500
| New | +$492K |
|
771
Karyopharm Therapeutics
KPTI
$42.2M
| $289K | 0.02% |
1,002
-4,802
| -83% | -$1.32M |
|
|
CMBT
772
CMB.TECH NV
CMBT
$5.27B
| $289K | 0.02% |
25,600
+13,200
| +106% | +$136K |
|
773
Fulton Financial
FULT
$4.5B
| $288K | 0.02% |
+25,084
| New | +$385K |
|
|
HES
774
DELISTED
Hess
HES
| $288K | 0.02% |
8,656
-5,087
| -37% | -$275K |
|
775
Melco Resorts & Entertainment
MLCO
$2.08B
| $288K | 0.02% |
23,200
-2,963
| -11% | -$56.6K |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.